BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16396838)

  • 1. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
    Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
    Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Law M; Young RJ; Babb JS; Peccerelli N; Chheang S; Gruber ML; Miller DC; Golfinos JG; Zagzag D; Johnson G
    Radiology; 2008 May; 247(2):490-8. PubMed ID: 18349315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
    Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
    Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.
    Brasil Caseiras G; Ciccarelli O; Altmann DR; Benton CE; Tozer DJ; Tofts PS; Yousry TA; Rees J; Waldman AD; Jäger HR
    Radiology; 2009 Nov; 253(2):505-12. PubMed ID: 19789244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results.
    Essig M; Waschkies M; Wenz F; Debus J; Hentrich HR; Knopp MV
    Radiology; 2003 Jul; 228(1):193-9. PubMed ID: 12832582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
    Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.
    Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z
    Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
    Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
    AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
    Aronen HJ; Gazit IE; Louis DN; Buchbinder BR; Pardo FS; Weisskoff RM; Harsh GR; Cosgrove GR; Halpern EF; Hochberg FH
    Radiology; 1994 Apr; 191(1):41-51. PubMed ID: 8134596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.
    Majchrzak K; Kaspera W; Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak H; Ładziński P
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1135-44. PubMed ID: 22425370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.
    Caseiras GB; Chheang S; Babb J; Rees JH; Pecerrelli N; Tozer DJ; Benton C; Zagzag D; Johnson G; Waldman AD; Jäger HR; Law M
    Eur J Radiol; 2010 Feb; 73(2):215-20. PubMed ID: 19201123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas.
    Ginat DT; Mangla R; Yeaney G; Schaefer PW; Wang H
    Acad Radiol; 2012 Aug; 19(8):986-90. PubMed ID: 22591719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.